Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Meet the new OCS director,
Dr. Emily S. Tonorezos.
Spotlight
Publication
March. 2021 — Disparities and Barriers to Pediatric Cancer Survivorship Care
This AHRQ Technical Brief was commissioned by NCI to support the development of a research agenda associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act.
Feature
Feb. 2021 — Request for Information (RFI)
Leveraging clinical trial populations in NCI’s national clinical trial network (NCTN) and community oncology research program (NCORP) for observational cancer survivorship studies.
Blog
Feb. 2021 — Cancer Currents Blog
Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven Pergam.
Funding Opportunities
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Quick Links
Featured Graph and Statistic
Rates of New Cancer Cases by Sex and Race/Ethnicity
For all cancers combined, Black men have the highest rate of new cancer diagnoses.
Cancer Survivor Statistics
It is estimated that there are 16.9 million cancer survivors in the United States. This represents approximately 5.0% of the population.